Livingbridge, a UK-based mid-market private equity investment firm, has completed a minority investment in T-Pro, a specialist in clinical document workflow software solutions founded in 2012 and headquartered in Dublin.
Livingbridge, a UK-based mid-market private equity investment firm, has completed a minority investment in T-Pro, a specialist in clinical document workflow software solutions founded in 2012 and headquartered in Dublin.
T-Pro’s AI powered speech technology aims to enable more efficient and accurate document workflows across a full spectrum of healthcare settings, allowing healthcare providers to voice enable their existing Electronic Patient Record, reduce traditional transcription costs, improve clerical efficiency and capture patient information effectively and efficiently from anywhere on any device.
T-Pro has grown rapidly in recent years via the launch of new software products and expansion of its customer base in Ireland, the UK, Australia, and New Zealand, acquiring Syberscribe in Melbourne in 2022. Livingbridge’s investment will enable T-Pro to continue developing its bdictation and speech products, further advance its AI capabilities, and support international expansion and acquisitions.
Livingbridge has been a longstanding investor across the healthcare and software sectors internationally for over 25 years and will support T-Pro via its global team based in London, Manchester, Melbourne and Boston.
Livingbridge was advised by IBI Corporate Finance, Eversheds, Allens, Grant Thornton, BDO and OC&C Strategy Australia.
T-Pro was advised by Houlihan Lokey, DLA Piper, PwC Strategy&, PwC and Intechnica.
